Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China, 510060
Welcome,         Profile    Billing    Logout  
 12 Trials 
31 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Yizhi
NCT03230799: Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Recruiting
N/A
100
RoW
minimal invasive lens surgery, traditional cataract surgery
Sun Yat-sen University
Congenital Cataract
06/22
12/22
NCT03605160: An Innovative Method Fluid-jet to to Remove Residual Lens Fibers

Active, not recruiting
N/A
740
RoW
traditional polish, fluid-jet
Sun Yat-sen University
Posterior Capsule Opacification
01/23
01/23
NCT05136950: Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation

Recruiting
N/A
228
RoW
Secondary in-the-bag IOL fixation, Secondary ciliary sulcus IOL fixation
Zhongshan Ophthalmic Center, Sun Yat-sen University
Lens Implantation, Intraocular
07/23
07/33
NCT03908359: Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Recruiting
N/A
100
RoW
traditional cataract surgery, minimal invasive lens surgery
Sun Yat-sen University
Congenital Cataract
11/23
12/23
NCT05628129: Effect of Mobile Communication on Congenital Ectopia Lentis Follow-up Adherence

Recruiting
N/A
114
RoW
smartphone application service and phone reminder
Zhongshan Ophthalmic Center, Sun Yat-sen University
Ectopia Lentis
10/24
11/24
NCT03589937: Ocular Development and Refractive Error Changes Among Children and Adolescent - A Longitudinal Study

Active, not recruiting
N/A
7050
RoW
Zhongshan Ophthalmic Center, Sun Yat-sen University
Myopia
07/24
07/24
DME HOME, NCT06610747: Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT

Not yet recruiting
N/A
308
RoW
Home-based Care Monitoring, Aflibercept 2Mg/0.05Ml Inj,Oph, Aflibercept 2-mg/0.05mL intravitreal ophthalmic injection, Laser Treatment, Standard Hospital/clinic-based Care Monitoring
Zhongshan Ophthalmic Center, Sun Yat-sen University, Dongguan Guangming Ophthalmic Hospital, The Second People's Hospital of Foshan
Diabetic Macular Edema
04/27
04/27
NCT05728762: Light Emitting Diodes With a Continuous Spectrum of 430-780nm for Myopia Prevention

Active, not recruiting
N/A
1920
RoW
Novel LEDs
Zhongshan Ophthalmic Center, Sun Yat-sen University
Myopia, Refractive Errors, Eye Diseases
12/25
12/25
NCT05654025: Follow up Study on Visual Prognosis and Complications of Ectopia Lentis Lens

Recruiting
N/A
604
RoW
Zhongshan Ophthalmic Center, Sun Yat-sen University
Ectopia Lentis, Dislocation, Lens
12/27
12/27
NCT05472844: The Cohort Study of Pediatric Cataract

Recruiting
N/A
5000
RoW
Zhongshan Ophthalmic Center, Sun Yat-sen University
Pediatric Cataract
01/32
02/32
NCT05223712: Artificial Intelligence System for the Detection and Prediction of Kidney Diseases Using Ocular Information

Recruiting
N/A
4000
RoW
Diagnostic Test: Chronic Kidney Diseases
Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University
Artificial Intelligence, Ophthalmology, Kidney Diseases
12/22
12/22
NCT05565547: Multimodal Equipment for Teleophthalmology Assessment (META)

Not yet recruiting
N/A
400
NA
META, Commercial devices
Zhongshan Ophthalmic Center, Sun Yat-sen University
Eye Diseases
03/23
05/23
AI, NCT05204095: Intelligent Cataract Screening With Portable Slit-lamp

Not yet recruiting
N/A
3000
RoW
Portable slit-lamp photography
Sun Yat-sen University
Catarct Screening, Artificial Intelligence
06/23
06/23
Liu, Zhenzhen
HELEN-006, NCT04547907: A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Recruiting
3
688
RoW
Nab-paclitaxel+ trastuzumab+ patuzumab, nab-PHP regimen group, Docetaxel+ carboplatin+ trastuzumab + patuzumab, TCbHP regimen group
Henan Cancer Hospital
Breast Cancer,HER2-positive
12/24
12/24
HELEN-009, NCT05242874: Anti-emetic Prophylaxis With or Without Dexamethasone

Completed
3
442
RoW
Fosaprepitant, tropisetron, and olanzapine-based antiemetic regimen, Fosaprepitant+Tropisetron+Olanzapine, Fosaprepitant, tropisetron, olanzapine, and dexamethasone-based antiemetic regimen, Fosaprepitant+Tropisetron+Olanzapine+Dexamethasone
Henan Cancer Hospital
Chemotherapy-induced Nausea and Vomiting
08/23
08/23
NCT06254742: A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Not yet recruiting
3
107
RoW
HHPG-19K Injection
Jiangsu HengRui Medicine Co., Ltd.
Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk
05/24
06/24
HELEN-008, NCT05063136: Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Recruiting
3
1979
RoW
Capecitabine+endocrine therapy, Experimental group, Placebo+endocrine therapy, Control group
Henan Cancer Hospital
Breast Cancer
09/25
09/28
NCT05474690: A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Withdrawn
3
456
RoW
Docetaxel + Carboplatin + Trastuzumab + Pertuzumab, TCbHP regimen group, (Epirubicin + Cyclophosphamide - Docetaxel) + (Trastuzumab + Pertuzumab), ECHP-THP regimen group
Henan Cancer Hospital
Breast Cancer, HER2-positive Breast Cancer
03/23
08/24
NCT04222790: A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Completed
2
159
RoW
monosialic gangliosides, experience group, Placebo, control group
Henan Cancer Hospital
Early Breast Cancer
04/22
04/22
NCT04664972: Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Completed
2
212
RoW
Docetaxel +doxorubicin+ cyclophosphamide, TAC regimen group, Docetaxel +Cisplatin, TP regimen group
Henan Cancer Hospital
Triple Negative Breast Cancer
11/22
11/22
NCT06276868: Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Recruiting
2
71
RoW
Dalcilib+letrozole+HP treatment group, experimental group
Henan Cancer Hospital
Breast Cancer, HER2-positive Breast Cancer
07/25
06/29
NCT06394661: Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Recruiting
2
109
RoW
Serplulimab+NabPE
Henan Cancer Hospital
Breast Cancer
12/25
12/28
BC-NEO-IIT-SHR-A1811, NCT05911958: A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

Recruiting
2
66
RoW
SHR-A1811 for injection, SHR-A1811 group
Henan Cancer Hospital
HER2 Low Breast Carcinoma
12/24
05/29
NCT05475678: Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Recruiting
2
369
RoW
(Carrelizumab + TCb) regimen, Carrelizumab +docetaxel + carboplatin, TCb regimen, docetaxel + carboplatin
Zhenzhen Liu
Breast Cancer, Triple Negative Breast Cancer, Camrelizumab
12/24
12/29
NCT05918328: Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

Recruiting
2
610
RoW
Albumin paclitaxel+trastuzumab+pyrrolitinib, Nab-PH+pyrrolitinib regimen, Docetaxel+Carboplatin+trastuzumab+Parstuzumab, TCbHP regimen
Henan Cancer Hospital
Breast Cancer, HER2-positive Breast Cancer
12/25
12/26
NCT05253053: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Recruiting
1/2
114
RoW
TT-00420, Combination Product: Atezolizumab, Combination Product: Nab-Paclitaxel
TransThera Sciences (Nanjing), Inc.
Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer, HER2-negative Breast Cancer, Triple Negative Breast Cancer, Small-cell Lung Cancer, Bladder Cancer, Prostate Cancer, Thyroid Cancer, Gastric Cancer, Gallbladder Cancer
09/24
12/24
NCT05136950: Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation

Recruiting
N/A
228
RoW
Secondary in-the-bag IOL fixation, Secondary ciliary sulcus IOL fixation
Zhongshan Ophthalmic Center, Sun Yat-sen University
Lens Implantation, Intraocular
07/23
07/33
NCT06518135: Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer

Recruiting
N/A
508
RoW
SLNB group, experimental group
Henan Cancer Hospital
Sentinel Lymph Node Biopsy
03/28
03/28
NCT06095323: Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema

Recruiting
N/A
480
RoW
compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg)
Zhenzhen Liu
Breast Cancer-related Arm Lymphedema
10/25
10/25
CAPPELLA, NCT05512286: Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction

Recruiting
N/A
80
RoW
Preoperative radiotherapy, Postmastectomy radiotherapy
Fudan University, Huashan Hospital, Hunan Cancer Hospital, Cancer Hospital of Guangxi Medical University, Yunnan Cancer Hospital, Zhejiang Cancer Hospital, Henan Cancer Hospital
Breast Cancer
07/26
10/27
NCT05472844: The Cohort Study of Pediatric Cataract

Recruiting
N/A
5000
RoW
Zhongshan Ophthalmic Center, Sun Yat-sen University
Pediatric Cataract
01/32
02/32

Download Options